396716-14-6

TACE FRET Substrate I TACE FRET SUBSTRATE III DABCYL-LAQAVRSSSR-EDANS DABCYL-TNF-α-EDANS (-4 to +6) TACE SUBSTRATE III, FLUOROGENIC ADAM-17 SUBSTRATE II, FLUOROGENIC ADAM-17 SUBSTRATE III, FLUOROGENIC DABCYL-TNF-a-EDANS: -4 to +6, human DABCYL-TNF-α-EDANS (-4 to +6) (human) DABCYL-TNF-α-EDANS (-4 to +6) (human) DABCYL-TNF-ALPHA-EDANS (-4 TO +6) (HUMAN) TNF-ALPHA CONVERTASE ENZYME SUBSTRATE, FLUOROGENIC DABCYL-LEU-ALA-GLN-ALA-VAL-ARG-SER-SER-SER-ARG-EDANS TNF-ALPHA CONVERTASE ENZYME SUBSTRATE II, FLUOROGENIC DABCYL-TUMOR NECROSIS FACTOR-ALPHA-EDANS (-4 TO +6) (HUMAN) DABCYL-TNF-α-EDANS (-4 to +6) (human) trifluoroacetate salt DABCYL-TNF-alpha-EDANS (-4 to +6) (human) trifluoroacetate salt L-Argininamide,N-[4-[[4-(dimethylamino)phenyl]azo]benzoyl]-L-leucyl-L-alanyl-L-glutaminyl-L-alanyl-L-valyl-L-arginyl-L-seryl-L-seryl-L-seryl-N-[2-[(5-sulfo-1-naphthalenyl)amino]ethyl]- L-Argininamide, N-[4-[[4-(dimethylamino)phenyl]azo]benzoyl]-L-leucyl-L-alanyl-L-glutaminyl-L-alanyl-L-valyl-L-arginyl-L-seryl-L-seryl-L-seryl-N-[2-[(5-sulfo-1-naphthalenyl)amino]ethyl]- (9CI)